Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Efficacy of ARCO [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating ARCO for Plasmodium falciparum malaria reports safety, tolerability, pharmacokinetics and efficacy data; the study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• ARCO

Snippet

Sponsor: Ifakara Health Institute | Conditions: Plasmodium Falciparum, Malaria, Falciparum | Phase 4 | Status: COMPLETED